Evaluation of outcome of primary pterygium excision combined with different techniques

---

Original Article

Author Details : Manjunath BH, Raksha V*

Volume : 7, Issue : 3, Year : 2021

Article Page : 268-272

https://doi.org/10.18231/j.ijooo.2021.055

Suggest article by email

Get Permission

---

Abstract

Objectives: To compare different techniques combined with excision in treatment of primary pterygium: Amniotic membrane transplant [AMG], Limbal-conjunctival autograft [CLAG], and mitomycin c with limbal-conjunctival autograft.[MMC+CLAG]
Materials and Methods : A prospective comparative study was performed in tertiary hospital on 105 patients satisfying the inclusion and exclusion criteria. Combined with excision, 35 eyes each were treated with AMG transplantation [Group 1] and CLAG [Group 2] for closure of defect. In 35 eyes low-dose mitomycin -C [0.02%] was applied on bare sclera for 1 minute and a CLAG was applied thereafter [Group 3]. Patients were followed up for 9 months.
Results: Study was conducted from June 2018 to April 2020 on patients of age 26 to 72 years with mean age of 46.3 ± 10 years with 42[40%] male and 63[60%] female. A statistically significant change [ paired t test, p<0> Conclusion: Pterygium excision followed by CLAG and MMC+CLAG are an effective way of reducing recurrence. However close monitoring is required for use of adjuvant MMC.AMG can be reserved in patients with bilateral pterygium, severe limbal stem cell loss and in need of glaucoma surgery.
 
Keywords: Pterygium, MMC, Amniotic membrane graft, CLAG, CLAG with MMC

How to cite : Manjunath Bh, Raksha V, Evaluation of outcome of primary pterygium excision combined with different techniques. IP Int J Ocul Oncol Oculoplasty 2021;7(3):268-272

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.